OPIOID RECOVERY CENTRE — PHUKET, THAILAND
Heroin Addiction Treatment
Evidence-based treatment for heroin dependence — from medically supervised detox and medication-assisted therapy to psychotherapeutic rehabilitation and long-term relapse prevention.
Table of Contents
Why Professional Treatment Is Essential
Heroin addiction — clinically termed opioid use disorder involving heroin — produces profound neurobiological changes that make self-directed recovery extraordinarily difficult. The drug’s rapid delivery of dopamine to the brain’s reward circuitry creates one of the most powerful reinforcement cycles of any substance, while physical dependence develops within days to weeks of regular use, trapping individuals in a cycle where continued use becomes necessary simply to avoid the severe discomfort of withdrawal.
Research published in the New England Journal of Medicine demonstrates that untreated heroin addiction carries a mortality rate 6–20 times higher than the general population, with overdose, infectious disease, and suicide accounting for the majority of excess deaths. However, engagement in evidence-based treatment reduces mortality by 50–75 percent and produces sustained remission in 40–60 percent of patients — outcomes comparable to treatment success rates for other chronic medical conditions such as diabetes and hypertension.
Professional treatment addresses heroin addiction at every level: the acute physical dependence that makes cessation so painful, the neurological adaptations that drive compulsive use, the psychological patterns that sustain the addiction cycle, and the social and environmental factors that increase relapse vulnerability. No single intervention addresses all these dimensions, which is why integrated, multimodal treatment programmes consistently produce the best outcomes.
Medical Detoxification
Medically supervised detoxification is the essential first step in heroin addiction treatment. Heroin withdrawal, while rarely fatal in otherwise healthy adults, produces intense physical and psychological distress that drives the vast majority of unsupervised withdrawal attempts to fail within 48–72 hours.
Withdrawal symptoms typically begin 6‒12 hours after the last dose and include severe muscle and bone pain, restless leg syndrome, profuse sweating and chills, nausea, vomiting, diarrhoea, abdominal cramping, insomnia, anxiety, and intense drug cravings. Symptoms peak at 48–72 hours and gradually resolve over 5–7 days, though post-acute symptoms (insomnia, dysphoria, cravings) can persist for weeks to months.
At Phuket Island Rehab, our medical detoxification protocol uses a combination of medications to manage withdrawal symptoms effectively, ensuring patient comfort while maintaining safety throughout the process.
| Medication | Purpose | Evidence Level |
|---|---|---|
| Buprenorphine (Subutex/Suboxone) | Withdrawal symptom relief, craving reduction | Strong (FDA-approved) |
| Clonidine | Autonomic symptoms (sweating, anxiety, restlessness) | Strong |
| Loperamide | Gastrointestinal symptoms | Moderate |
| NSAIDs / Paracetamol | Muscle and bone pain | Moderate |
| Trazodone / Mirtazapine | Insomnia, mood support | Moderate |
Medication-Assisted Treatment (MAT)
Medication-assisted treatment represents the most significant advance in heroin addiction treatment over the past three decades. MAT combines FDA-approved medications with psychotherapy and counselling to provide a comprehensive, evidence-based approach that addresses both the neurobiological and psychological dimensions of addiction.
Buprenorphine is a partial opioid agonist that activates mu-opioid receptors sufficiently to prevent withdrawal and reduce cravings, but with a “ceiling effect” that limits euphoria and dramatically reduces overdose risk. Buprenorphine can be initiated during the withdrawal phase (typically 12–24 hours after the last heroin dose) and either tapered over days to weeks or maintained long-term depending on individual clinical needs. Meta-analyses published in the Cochrane Database of Systematic Reviews demonstrate that buprenorphine maintenance reduces illicit opioid use by 60–80 percent and reduces overdose mortality by approximately 50 percent.
Naltrexone (extended-release injection, Vivitrol) is an opioid antagonist that completely blocks opioid receptors, preventing heroin from producing any euphoric effect. It is initiated after complete detoxification and provides 30 days of protection per injection. Naltrexone is particularly effective for highly motivated individuals, those with shorter addiction histories, and those facing external consequences (legal, professional) that reinforce treatment compliance.
Methadone is a full opioid agonist with a long half-life (24–36 hours) that prevents withdrawal, eliminates cravings, and blocks the euphoric effects of heroin through cross-tolerance. Methadone maintenance is the most extensively studied addiction treatment in medical history, with over 50 years of evidence demonstrating its effectiveness in reducing heroin use, criminal activity, HIV transmission, and mortality.
Evidence-Based Psychotherapy
While MAT addresses the neurobiological dimension of heroin addiction, psychotherapy is essential for addressing the cognitive, emotional, and behavioural patterns that sustain the addiction cycle and drive relapse.
Cognitive-Behavioural Therapy (CBT) helps patients identify and modify the automatic thoughts and behavioural patterns that trigger heroin use. CBT for opioid addiction targets specific cognitive distortions including catastrophic thinking about withdrawal, romanticisation of the drug experience, and permission-giving thoughts that rationalise relapse. Controlled trials demonstrate that CBT reduces opioid use and relapse rates by 30–50 percent when combined with MAT.
Contingency Management (CM) provides tangible rewards (vouchers, privileges) for verified drug-free urine samples. This approach leverages the brain’s reward circuitry to reinforce abstinence, effectively competing with the drug’s reinforcing properties. Meta-analyses consistently show CM produces the largest effect sizes of any psychosocial intervention for opioid use disorder.
Motivational Interviewing (MI) addresses the ambivalence that characterises many heroin-addicted individuals — the simultaneous desire to stop using and reluctance to face life without the drug’s emotional buffering. MI helps patients connect with their own motivations for change, increasing treatment engagement and retention.
Trauma-focused therapy (EMDR, trauma-focused CBT) is frequently essential because unresolved psychological trauma is present in an estimated 50–70 percent of individuals with heroin addiction. Trauma processing reduces the emotional pain that drives self-medication with opioids and addresses the root cause of vulnerability to addiction.
| Treatment Component | Role | Optimal Timing |
|---|---|---|
| Medical detoxification | Safe withdrawal, stabilisation | Days 1–7 |
| MAT initiation | Craving control, relapse prevention | During or immediately after detox |
| Individual CBT | Cognitive restructuring, coping skills | Begins week 1, continues 12–16+ sessions |
| Group therapy | Peer support, social skills, normalisation | Daily during residential stay |
| Trauma processing | Address root emotional drivers | After stabilisation, weeks 2–8+ |
| Aftercare planning | Sustained recovery support | Begins mid-programme, continues 12+ months |
Holistic Recovery Support
Heroin addiction affects every dimension of a person’s life — physical health, mental wellbeing, relationships, occupational functioning, and sense of purpose. Comprehensive treatment addresses all these domains through holistic interventions that complement medical and psychotherapeutic care.
Physical rehabilitation begins with nutritional restoration (chronic heroin use produces significant malnutrition and micronutrient depletion) and progresses to structured exercise programming. Regular exercise increases endogenous endorphin production, providing natural activation of the same opioid receptors that heroin hijacks, and has been shown to reduce cravings and improve mood during recovery.
Mindfulness and stress management training equips patients with non-chemical tools for managing the emotional states that previously triggered heroin use. Mindfulness-Based Relapse Prevention (MBRP) has demonstrated particular efficacy for opioid use disorder, teaching patients to observe cravings and negative emotions without reflexive avoidance through drug use.
Life skills rehabilitation addresses the practical deficits that often accompany chronic heroin addiction. Financial management, employment readiness, communication skills, and healthy relationship building are integrated into the treatment programme to support successful reintegration into community life after discharge.
Family involvement is encouraged whenever possible. Heroin addiction profoundly affects family systems, and family therapy or education sessions help repair damaged relationships, establish healthy boundaries, and build the supportive home environment that facilitates sustained recovery.
Why Residential Treatment in Phuket
Residential treatment provides critical advantages for heroin addiction that outpatient settings cannot match. Complete removal from drug-associated environments, people, and triggers eliminates the constant cue exposure that drives relapse during early recovery. Twenty-four-hour medical monitoring ensures safety during detoxification and medication initiation. Structured daily programming replaces the chaotic, drug-centred lifestyle with predictable routines that support healing.
At Phuket Island Rehab, the tropical Phuket setting adds a therapeutic dimension that few treatment centres can offer. The warm climate, natural surroundings, and distance from familiar stressors create an environment that naturally supports nervous system calming and emotional regulation. Our programme integrates medically supervised detox, MAT when indicated, intensive psychotherapy, physical fitness, nutritional rehabilitation, and mindfulness training into a comprehensive recovery framework tailored to each patient’s specific clinical needs.
Frequently Asked Questions
How long does heroin addiction treatment take?
Medical detoxification typically requires 5–10 days. A comprehensive residential treatment programme lasts 28–90 days depending on addiction severity, co-occurring conditions, and individual progress. Aftercare support, including ongoing therapy and potentially medication maintenance, continues for 6–12 months or longer. Research demonstrates that longer treatment duration consistently produces better long-term outcomes.
Is medication-assisted treatment just “replacing one drug with another”?
No. This is a persistent misconception. MAT medications like buprenorphine and methadone are prescribed at stable therapeutic doses that do not produce euphoria, impairment, or the chaotic cycle of intoxication and withdrawal that characterises active addiction. They normalise brain chemistry, eliminate cravings, prevent withdrawal, and allow patients to function fully in work, relationships, and daily life. The analogy is comparable to insulin for diabetes — a medication that corrects a physiological imbalance caused by a chronic medical condition.
What is the success rate for heroin addiction treatment?
Treatment success depends on the metric used and the treatment approach. Medication-assisted treatment combined with psychotherapy produces sustained remission rates of 40–60 percent at one year, with continued improvement over longer follow-up periods. Treatment engagement reduces overdose mortality by 50–75 percent. These outcomes compare favourably with treatment success rates for other chronic medical conditions.
Can heroin addiction be cured?
Current medical understanding classifies opioid use disorder as a chronic, relapsing condition similar to diabetes or hypertension — manageable with appropriate treatment but requiring ongoing attention. Many individuals achieve years or decades of sustained recovery, and some eventually discontinue all medications. The key message is that heroin addiction is treatable and recovery is achievable with the right support.
Why choose Phuket Island Rehab for heroin addiction treatment?
Our programme combines medical expertise in opioid detoxification and medication-assisted treatment with intensive psychotherapy specifically targeting the cognitive and emotional patterns that sustain heroin addiction. The residential Phuket setting provides essential environmental change, physical safety, and a healing atmosphere that supports the comprehensive recovery process. Our clinical team’s experience with complex opioid cases ensures that each patient receives individualised care from admission through aftercare.
Clinical Reviewer: Dr. Ponlawat Pitsuwan, Physician | Publisher: Phuket Island Rehab | Last Updated: April 2026 | Clinical Entities: Opioid Use Disorder, Heroin Detoxification, Buprenorphine, Naltrexone (Vivitrol), Methadone Maintenance, Medication-Assisted Treatment, Cognitive-Behavioural Therapy, Contingency Management, Motivational Interviewing, EMDR, Mindfulness-Based Relapse Prevention